Wednesday, October 05, 2022 10:00:11 PM
The CE part is historical, pre-NDTP, pre-custodial take over of the abandoned shell days, and there is no excuse for it now, except to block buying of shares. But until it is changed to Pink Current by OTC Markets (only they can do that), it is still also EM Expert market and thus really no different than CE status now days.
The Shell part was a different story, that should have been settled by recent filings.
I am convinced the delay the last 2+ years, was due to the problems the Pandemic caused... We already heard about Hovis's health issues (shit happens). Thus why they had to scramble and replace Hovis and the CEO/director.
Only the major shareholders who control who is the CEO/Director and the current CEO can solve this. They have way more to loose than we do. So lets hope they continue to get us over the finish line.
The Shell part was a different story, that should have been settled by recent filings.
I am convinced the delay the last 2+ years, was due to the problems the Pandemic caused... We already heard about Hovis's health issues (shit happens). Thus why they had to scramble and replace Hovis and the CEO/director.
Only the major shareholders who control who is the CEO/Director and the current CEO can solve this. They have way more to loose than we do. So lets hope they continue to get us over the finish line.
Recent NDTP News
- NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant • GlobeNewswire Inc. • 02/05/2026 02:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog • GlobeNewswire Inc. • 01/14/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s wholly owned subsidiary, Good Salt Life, Inc., Advances into AI-Robotics for Unmanned Hospital Disinfection • GlobeNewswire Inc. • 01/12/2026 01:00:00 PM
- NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant • GlobeNewswire Inc. • 01/08/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals • GlobeNewswire Inc. • 12/19/2025 01:36:01 PM
- Good Salt Life, Inc.'s Induction Charge Delivery Systems Deployed to Protect Show Horses from Widespread EHV-1 Outbreak • ACCESS Newswire • 11/26/2025 01:00:00 PM
- NDT Pharmaceuticals' Subsidiary, Good Salt(TM) Life, Secures Major Government Contract, Deploying Advanced Biosafety Ecosystem in Tennessee State Prisons • ACCESS Newswire • 11/24/2025 02:00:00 PM
- FatPipe, Jackpot Digital, and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 11/07/2025 02:00:00 PM
- 60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 10/31/2025 01:00:00 PM
- Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5 • ACCESS Newswire • 10/30/2025 12:30:00 PM
- NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line • ACCESS Newswire • 10/21/2025 12:30:00 PM
- Baptist Hospital Enhances Patient Safety and Air Quality with Good Salt(TM) Life's ByoCart(TM) Disinfection System • ACCESS Newswire • 10/13/2025 12:30:00 PM
- Good Salt Life Expands EPA Registrations and Anticipates New Milestone • ACCESS Newswire • 10/09/2025 12:30:00 PM
- NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets • ACCESS Newswire • 09/23/2025 01:10:00 PM
